Proteomics Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
Description
Global Proteomics Market: Industry Overview
The global proteomics market was valued at approximately $29.60 billion in 2025 and is projected to grow $96.28 billion by 2035, at a CAGR of around 12.52%. The global proteomics market is witnessing accelerated growth driven by the rising prevalence of chronic and neurodegenerative diseases, continuous technological advancements, and the increasing demand for personalized medicine. Proteomics has emerged as a transformative field, enabling in-depth analysis of protein structures, functions, and interactions, which are critical for understanding disease mechanisms and developing targeted therapies. The integration of artificial intelligence, machine learning, and multi-omics platforms is revolutionizing the proteomics workflow, from biomarker discovery to clinical translation, by enabling faster, more accurate, and cost-effective analyses. AI-enabled systems are streamlining data interpretation, uncovering complex protein interaction networks, and facilitating early disease detection through predictive modeling.
Moreover, autonomous discovery platforms and generative AI tools are empowering researchers to perform iterative design, test, and optimize cycles with minimal human intervention, accelerating drug discovery and diagnostics. Pharmaceutical, biotechnology, and contract research organizations are increasingly collaborating with AI-driven startups and technology providers to enhance scalability, improve data integration, and enable precision-driven insights. Strategic partnerships, funding initiatives, and mergers are strengthening the commercialization of advanced proteomic platforms, while cloud-based and on-premise solutions are expanding accessibility across research and clinical settings. Collectively, these factors are reshaping the global proteomics landscape, improving research productivity, and positioning the market for sustained long-term growth.
Global Proteomics Market Lifecycle Stage
The global proteomics market currently stands at the growth and acceleration stage of its lifecycle, transitioning from early adoption toward broader market maturity. Over the past decade, the field has evolved from academic and exploratory research into a strategically critical component of precision medicine, clinical diagnostics, and drug discovery. This shift has been fueled by rapid advancements in mass spectrometry, liquid chromatography, and affinity-based proteomic platforms, alongside the integration of artificial intelligence, machine learning, and multi-omics analytics.
The expansion of the global proteomics market is underpinned by a robust convergence of technological innovation and clinical utility. Continuous improvements in data-independent acquisition (DIA) methods, single-cell and spatial proteomics, and bioinformatics pipelines are enabling high-throughput, high-sensitivity protein profiling. At the same time, commercial players are scaling platform accessibility through automation, cloud-enabled analytics, and service-based delivery models. These trends indicate strong forward momentum as proteomics moves beyond research applications into clinical and translational domains.
While the market exhibits high innovation intensity, its penetration remains uneven across regions and end-user segments. Developed markets in North America and Europe demonstrate near-mainstream adoption within pharma, biotech, and academic research ecosystems. Conversely, adoption in emerging regions is still in its early growth phase, constrained by high capital costs, infrastructure gaps, and limited skilled personnel. This bifurcation positions the market globally within a mid-to-late growth phase, with significant opportunities for expansion through affordable instrumentation, service partnerships, and decentralized proteomic networks.
In summary, the global proteomics market is in a dynamic growth stage, characterized by technological disruption, capital inflows, and expanding end-user adoption. Over the next few years, the industry is expected to move toward early maturity, with broader clinical integration, standardization of workflows, and consolidation among technology providers.
Market Segmentation:
Segmentation 1: By Offering
Sample Preparation
Proteomics Technologies
Reagents and Consumables
Instruments
Software
Proteomics Services
Proteomics technologies segment is expected to account for the largest share of the global proteomics market. This can be attributed to the widespread adoption of advanced analytical platforms, including mass spectrometry, chromatography systems, and specialized software, which are fundamental to conducting high-throughput and high-resolution proteomic analyses. The continuous innovation in instrumentation, growing demand for platform-specific reagents, and increasing integration of AI and cloud-based tools have further strengthened the dominance of this segment. Additionally, the high capital investment associated with proteomic technologies contributes significantly to overall market value.
Segmentation 2: By Technology
Mass Spectrometry-Based Proteomics
Chromatography-Based Proteomics
Protein Microarrays
Single-Cell Proteomics
NGS-Based Proteomics
Others
Based on technology, mass spectrometry-based proteomics is expected to dominate the global proteomics market in 2024. This is primarily due to its unmatched sensitivity, accuracy, and versatility in identifying and quantifying proteins across diverse biological samples. Mass spectrometry has become the gold standard in proteomic research owing to its ability to support both discovery and targeted workflows, detect post-translational modifications, and handle complex sample matrices. Its integration into clinical and translational research has further expanded its adoption across pharmaceutical, academic, and diagnostic settings.
Segmentation 3: By Application
Biomarker Discovery and Validation
Proteome Profiling and Mapping
Drug Discovery and Development
Discovery
Preclinical
Clinical
Companion Diagnostics
Protein-Protein Interactions
In 2024, biomarker discovery and validation segment is projected to hold the largest share of the global proteomics market. This dominance is driven by its wide usage across multiple therapeutic areas, integral to precision medicine, and heavily funded for its role in early-stage research, diagnostics, and drug development. Its broad applicability and reliance on diverse proteomics technologies make it the most in-demand application
Segmentation 4: By End User
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratory & Hospitals
Contract Research Organizations
Based on end-user segmentation, academic and research institutions are expected to account for the largest share of the global proteomics market in 2024. This is primarily driven by the high volume of basic and translational research activities conducted in universities, government-funded laboratories, and public research centers. These institutions are at the forefront of exploring novel proteomic methodologies, biomarker discovery, and systems biology, often supported by significant public and private funding. Additionally, the availability of advanced infrastructure, collaborations with industry players, and a strong focus on innovation have positioned academic and research institutions as key drivers of proteomics adoption globally.
Segmentation 5: By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Based on region, North America is expected to hold the largest share of the global proteomics market in 2024, accounting for 44.69%. This dominance is attributed to the region's well-established research infrastructure, strong presence of key market players, high investment in life sciences R&D, and widespread adoption of advanced proteomic technologies in both academic and clinical settings. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period (2025–2035), with a CAGR of 13.86%, driven by increasing government funding for biomedical research, rapid expansion of healthcare infrastructure, growing focus on precision medicine, and a rising number of collaborations between global companies and regional research institutions.
Demand – Drivers and Limitations
Demand Drivers for the Global Proteomics Market:
Rising Prevalence of Chronic Diseases
Continuous Technological Advancements
Increasing Demand for Personalized Medicine
Limitations for the Global Proteomics Market:
High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
Shortage of Skilled Professionals
How can this report add value to an organization?
Product/Innovation: This report enables organizations to identify high-value opportunities in the global proteomics market. It guides R&D investment strategies, technology adoption, and pipeline optimization, helping companies prioritize initiatives that accelerate biomarker discovery, disease diagnostics, and therapeutic development. By highlighting emerging technologies, strategic collaborations, and platform scalability, this report helps organizations strengthen their competitive positioning and capitalize on the rapid expansion of proteomics across research, clinical, and pharmaceutical applications.
Growth/Marketing: The report delivers in-depth insights into regional adoption trends, emerging markets, and partnership opportunities, supporting strategic market entry and commercialization planning. It enables companies to identify growth potential across offering, technology, application, and end-user segments. By understanding regional R&D investments, regulatory frameworks, and technology adoption rates, organizations can refine marketing, licensing, and collaboration strategies, maximize visibility, and increase return on investment in a competitive global landscape.
Competitive: This report provides comprehensive company profiling, competitive benchmarking, highlighting strategic collaborations, funding activities, mergers, acquisitions, and technology adoption trends. Stakeholders gain a clear understanding of competitor focus areas, R&D priorities, and market positioning. This intelligence allows organizations to identify gaps, anticipate market shifts, and formulate strategies to differentiate themselves, optimize market entry, and maintain leadership in the proteomics ecosystem.
Key Market Players and Competitive Landscape
The global proteomics market is characterized by a highly competitive and evolving landscape, with participation from both well-established and emerging start-up companies. The key players include leading providers of life science instruments, consumables, and bioinformatics solutions offering advanced technologies such as mass spectrometry, protein microarrays, chromatography systems, and data analysis platforms as well as service providers.
Key players include:
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bruker Corporation
Carterra, Inc.
Danaher Corporation
DiaSorin S.P.A.
Erisyon Inc.
Illumina, Inc.
RareCyte Inc.
Quanterix Corporation
Quantum-Si Incorporated
Shimadzu Corporation
Standard BioTools Inc.
Thermo Fisher Scientific Inc.
Waters Corporation
Competitive benchmarking highlights mergers and acquisitions, funding activities, licensing deals, and collaborations with pharmaceutical organizations, reflecting the growing emphasis on innovation and speed-to-market. Companies are evaluated based on market presence, technological capabilities, strategic initiatives, and product portfolios. Detailed company profiles cover target end users, technological focus areas, and expert analyst perspectives, providing stakeholders with actionable insights into investment opportunities, market positioning, and strategic growth pathways. This intelligence enables organizations to effectively align their R&D and commercialization strategies with emerging market dynamics of the global proteomics market.
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
The global proteomics market was valued at approximately $29.60 billion in 2025 and is projected to grow $96.28 billion by 2035, at a CAGR of around 12.52%. The global proteomics market is witnessing accelerated growth driven by the rising prevalence of chronic and neurodegenerative diseases, continuous technological advancements, and the increasing demand for personalized medicine. Proteomics has emerged as a transformative field, enabling in-depth analysis of protein structures, functions, and interactions, which are critical for understanding disease mechanisms and developing targeted therapies. The integration of artificial intelligence, machine learning, and multi-omics platforms is revolutionizing the proteomics workflow, from biomarker discovery to clinical translation, by enabling faster, more accurate, and cost-effective analyses. AI-enabled systems are streamlining data interpretation, uncovering complex protein interaction networks, and facilitating early disease detection through predictive modeling.
Moreover, autonomous discovery platforms and generative AI tools are empowering researchers to perform iterative design, test, and optimize cycles with minimal human intervention, accelerating drug discovery and diagnostics. Pharmaceutical, biotechnology, and contract research organizations are increasingly collaborating with AI-driven startups and technology providers to enhance scalability, improve data integration, and enable precision-driven insights. Strategic partnerships, funding initiatives, and mergers are strengthening the commercialization of advanced proteomic platforms, while cloud-based and on-premise solutions are expanding accessibility across research and clinical settings. Collectively, these factors are reshaping the global proteomics landscape, improving research productivity, and positioning the market for sustained long-term growth.
Global Proteomics Market Lifecycle Stage
The global proteomics market currently stands at the growth and acceleration stage of its lifecycle, transitioning from early adoption toward broader market maturity. Over the past decade, the field has evolved from academic and exploratory research into a strategically critical component of precision medicine, clinical diagnostics, and drug discovery. This shift has been fueled by rapid advancements in mass spectrometry, liquid chromatography, and affinity-based proteomic platforms, alongside the integration of artificial intelligence, machine learning, and multi-omics analytics.
The expansion of the global proteomics market is underpinned by a robust convergence of technological innovation and clinical utility. Continuous improvements in data-independent acquisition (DIA) methods, single-cell and spatial proteomics, and bioinformatics pipelines are enabling high-throughput, high-sensitivity protein profiling. At the same time, commercial players are scaling platform accessibility through automation, cloud-enabled analytics, and service-based delivery models. These trends indicate strong forward momentum as proteomics moves beyond research applications into clinical and translational domains.
While the market exhibits high innovation intensity, its penetration remains uneven across regions and end-user segments. Developed markets in North America and Europe demonstrate near-mainstream adoption within pharma, biotech, and academic research ecosystems. Conversely, adoption in emerging regions is still in its early growth phase, constrained by high capital costs, infrastructure gaps, and limited skilled personnel. This bifurcation positions the market globally within a mid-to-late growth phase, with significant opportunities for expansion through affordable instrumentation, service partnerships, and decentralized proteomic networks.
In summary, the global proteomics market is in a dynamic growth stage, characterized by technological disruption, capital inflows, and expanding end-user adoption. Over the next few years, the industry is expected to move toward early maturity, with broader clinical integration, standardization of workflows, and consolidation among technology providers.
Market Segmentation:
Segmentation 1: By Offering
Sample Preparation
Proteomics Technologies
Reagents and Consumables
Instruments
Software
Proteomics Services
Proteomics technologies segment is expected to account for the largest share of the global proteomics market. This can be attributed to the widespread adoption of advanced analytical platforms, including mass spectrometry, chromatography systems, and specialized software, which are fundamental to conducting high-throughput and high-resolution proteomic analyses. The continuous innovation in instrumentation, growing demand for platform-specific reagents, and increasing integration of AI and cloud-based tools have further strengthened the dominance of this segment. Additionally, the high capital investment associated with proteomic technologies contributes significantly to overall market value.
Segmentation 2: By Technology
Mass Spectrometry-Based Proteomics
Chromatography-Based Proteomics
Protein Microarrays
Single-Cell Proteomics
NGS-Based Proteomics
Others
Based on technology, mass spectrometry-based proteomics is expected to dominate the global proteomics market in 2024. This is primarily due to its unmatched sensitivity, accuracy, and versatility in identifying and quantifying proteins across diverse biological samples. Mass spectrometry has become the gold standard in proteomic research owing to its ability to support both discovery and targeted workflows, detect post-translational modifications, and handle complex sample matrices. Its integration into clinical and translational research has further expanded its adoption across pharmaceutical, academic, and diagnostic settings.
Segmentation 3: By Application
Biomarker Discovery and Validation
Proteome Profiling and Mapping
Drug Discovery and Development
Discovery
Preclinical
Clinical
Companion Diagnostics
Protein-Protein Interactions
In 2024, biomarker discovery and validation segment is projected to hold the largest share of the global proteomics market. This dominance is driven by its wide usage across multiple therapeutic areas, integral to precision medicine, and heavily funded for its role in early-stage research, diagnostics, and drug development. Its broad applicability and reliance on diverse proteomics technologies make it the most in-demand application
Segmentation 4: By End User
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratory & Hospitals
Contract Research Organizations
Based on end-user segmentation, academic and research institutions are expected to account for the largest share of the global proteomics market in 2024. This is primarily driven by the high volume of basic and translational research activities conducted in universities, government-funded laboratories, and public research centers. These institutions are at the forefront of exploring novel proteomic methodologies, biomarker discovery, and systems biology, often supported by significant public and private funding. Additionally, the availability of advanced infrastructure, collaborations with industry players, and a strong focus on innovation have positioned academic and research institutions as key drivers of proteomics adoption globally.
Segmentation 5: By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Based on region, North America is expected to hold the largest share of the global proteomics market in 2024, accounting for 44.69%. This dominance is attributed to the region's well-established research infrastructure, strong presence of key market players, high investment in life sciences R&D, and widespread adoption of advanced proteomic technologies in both academic and clinical settings. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period (2025–2035), with a CAGR of 13.86%, driven by increasing government funding for biomedical research, rapid expansion of healthcare infrastructure, growing focus on precision medicine, and a rising number of collaborations between global companies and regional research institutions.
Demand – Drivers and Limitations
Demand Drivers for the Global Proteomics Market:
Rising Prevalence of Chronic Diseases
Continuous Technological Advancements
Increasing Demand for Personalized Medicine
Limitations for the Global Proteomics Market:
High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
Shortage of Skilled Professionals
How can this report add value to an organization?
Product/Innovation: This report enables organizations to identify high-value opportunities in the global proteomics market. It guides R&D investment strategies, technology adoption, and pipeline optimization, helping companies prioritize initiatives that accelerate biomarker discovery, disease diagnostics, and therapeutic development. By highlighting emerging technologies, strategic collaborations, and platform scalability, this report helps organizations strengthen their competitive positioning and capitalize on the rapid expansion of proteomics across research, clinical, and pharmaceutical applications.
Growth/Marketing: The report delivers in-depth insights into regional adoption trends, emerging markets, and partnership opportunities, supporting strategic market entry and commercialization planning. It enables companies to identify growth potential across offering, technology, application, and end-user segments. By understanding regional R&D investments, regulatory frameworks, and technology adoption rates, organizations can refine marketing, licensing, and collaboration strategies, maximize visibility, and increase return on investment in a competitive global landscape.
Competitive: This report provides comprehensive company profiling, competitive benchmarking, highlighting strategic collaborations, funding activities, mergers, acquisitions, and technology adoption trends. Stakeholders gain a clear understanding of competitor focus areas, R&D priorities, and market positioning. This intelligence allows organizations to identify gaps, anticipate market shifts, and formulate strategies to differentiate themselves, optimize market entry, and maintain leadership in the proteomics ecosystem.
Key Market Players and Competitive Landscape
The global proteomics market is characterized by a highly competitive and evolving landscape, with participation from both well-established and emerging start-up companies. The key players include leading providers of life science instruments, consumables, and bioinformatics solutions offering advanced technologies such as mass spectrometry, protein microarrays, chromatography systems, and data analysis platforms as well as service providers.
Key players include:
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bruker Corporation
Carterra, Inc.
Danaher Corporation
DiaSorin S.P.A.
Erisyon Inc.
Illumina, Inc.
RareCyte Inc.
Quanterix Corporation
Quantum-Si Incorporated
Shimadzu Corporation
Standard BioTools Inc.
Thermo Fisher Scientific Inc.
Waters Corporation
Competitive benchmarking highlights mergers and acquisitions, funding activities, licensing deals, and collaborations with pharmaceutical organizations, reflecting the growing emphasis on innovation and speed-to-market. Companies are evaluated based on market presence, technological capabilities, strategic initiatives, and product portfolios. Detailed company profiles cover target end users, technological focus areas, and expert analyst perspectives, providing stakeholders with actionable insights into investment opportunities, market positioning, and strategic growth pathways. This intelligence enables organizations to effectively align their R&D and commercialization strategies with emerging market dynamics of the global proteomics market.
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
Table of Contents
197 Pages
- Executive Summary
- Scope and Definition
- 1 Market: Industry Outlook
- 1.1 Market Overview and Ecosystem
- 1.2 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
- 1.3 Supply Chain Analysis
- 1.4 Market Dynamics
- 1.4.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment, 2024-2035
- 1.5 Trends
- 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
- 1.5.2 Growing Proteomics Research to Identify Disease Biomarkers
- 1.5.3 Significant Number of Collaborations among Market Players
- 1.6 Market Dynamics
- 1.6.1 Market Drivers
- 1.6.1.1 Rising Prevalence of Chronic Diseases
- 1.6.1.2 Continuous Technological Advancements
- 1.6.1.3 Increasing Demand for Personalized Medicine
- 1.6.2 Market Challenges
- 1.6.2.1 High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
- 1.6.2.2 Shortage of Skilled Professionals
- 1.6.3 Business Strategies
- 1.6.3.1 Key Product Launch/Expansion
- 1.6.4 Corporate Strategies
- 1.6.4.1 Key Partnerships
- 1.6.4.2 Key Funding and Grants
- 1.6.4.3 Key Merger and Acquisitions
- 1.6.5 Market Opportunities
- 1.6.5.1 Expanding Proteomics Market in Emerging Regions through Affordable Technologies
- 1.7 Regulatory Landscape/Compliance
- 1.7.1 U.S.
- 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
- 1.7.1.2 Regulatory Requirements for Research Use Only (RUO) Products
- 1.7.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Proteomics Labs
- 1.7.2 Europe
- 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
- 1.7.2.1.1 EU Medical Device Regulation
- 1.7.2.1.2 EU In Vitro Diagnostic Regulation
- 1.7.2.1.3 Regulatory Requirements for Clinical Proteomics Labs in the EU
- 1.7.3 Rest-of-the-World
- 1.7.3.1 China
- 1.7.3.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
- 1.7.3.2 Japan
- 1.7.3.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
- 1.7.3.3 Brazil
- 1.7.3.3.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
- 1.7.3.3.2 Regulatory Requirements for Clinical Proteomics Labs in Brazil
- 1.8 Patent Analysis
- 1.8.1 Patent Analysis (by Year)
- 1.8.2 Patent Analysis (by Country)
- 1.9 Product Benchmarking
- 2 Offering
- 2.1 Offering Summary
- 2.2 Global Proteomics Market (by Offering)
- 2.2.1 Sample Preparation
- 2.2.2 Proteomics Technologies
- 2.2.2.1 Reagents and Consumables
- 2.2.2.1.1 MS-Based Reagents
- 2.2.2.1.2 Chromatography-Based Reagents
- 2.2.2.1.3 Protein Microarray Reagents
- 2.2.2.1.4 Single-Cell Analysis Reagents
- 2.2.2.1.5 NGS-Based Reagents
- 2.2.2.1.6 Other Reagents
- 2.2.2.2 Instruments
- 2.2.2.2.1 Mass Spectrometers
- 2.2.2.2.2 Chromatography Systems
- 2.2.2.2.3 Protein Microarrays
- 2.2.2.2.4 Single-Cell Analysis Instruments
- 2.2.2.2.5 NGS Instruments
- 2.2.2.2.6 Other Instruments
- 2.2.2.3 Software
- 2.2.2.3.1 AI-Based Proteomics Analysis Tools
- 2.2.2.3.2 Spatial Proteomics Data Analytic Software
- 2.2.2.3.3 Cloud-Based Platforms
- 2.2.3 Proteomics Services
- 3 Application
- 3.1 Application Summary
- 3.2 Global Proteomics Market (by Application)
- 3.2.1 Biomarker Discovery and Validation
- 3.2.2 Proteome Profiling and Mapping
- 3.2.3 Drug Discovery and Development
- 3.2.3.1 Discovery
- 3.2.3.1.1 Target Identification and Validation
- 3.2.3.1.2 Others
- 3.2.3.2 Preclinical
- 3.2.3.3 Clinical
- 3.2.4 Companion Diagnostics
- 3.2.5 Protein-Protein Interactions
- 4 Technology
- 4.1 Technology Summary
- 4.2 Global Proteomics Market (by Technology)
- 4.2.1 Mass Spectrometry-Based Proteomics
- 4.2.2 Chromatography-Based Proteomics
- 4.2.3 Protein Microarray
- 4.2.4 Single-Cell Proteomics
- 4.2.5 NGS-Based Proteomics
- 4.2.6 Other Technologies
- 5 End User
- 5.1 End User Summary
- 5.2 Global Proteomics Market (by End User)
- 5.2.1 Academic and Research Institutions
- 5.2.2 Pharmaceutical and Biotechnology Companies
- 5.2.3 Hospitals and Clinical Diagnostics Laboratories
- 5.2.4 Contract Research Organizations
- 6 Region
- 6.1 Regional Summary
- 6.2 North America
- 6.2.1 Regional Overview
- 6.2.2 Driving Factors for Market Growth
- 6.2.3 Factors Challenging the Market
- 6.2.4 By Offering
- 6.2.4.1 By Proteomics Technologies
- 6.2.5 By Application
- 6.2.6 By Country
- 6.2.6.1 U.S.
- 6.2.6.1.1 By Offering
- 6.2.6.1.2 Application
- 6.2.6.2 Canada
- 6.2.6.2.1 By Offering
- 6.2.6.2.2 By Application
- 6.3 Europe
- 6.3.1 Regional Overview
- 6.3.2 Driving Factors for Market Growth
- 6.3.3 Factors Challenging the Market
- 6.3.4 By Offering
- 6.3.4.1 By Proteomics Technologies
- 6.3.5 By Application
- 6.3.6 By Country
- 6.3.6.1 U.K.
- 6.3.6.1.1 By Offering
- 6.3.6.1.2 By Application
- 6.3.6.2 Germany
- 6.3.6.2.1 By Offering
- 6.3.6.2.2 By Application
- 6.3.6.3 France
- 6.3.6.3.1 By Offering
- 6.3.6.3.2 By Application
- 6.3.6.4 Italy
- 6.3.6.4.1 By Offering
- 6.3.6.4.2 By Application
- 6.3.6.5 Spain
- 6.3.6.5.1 By Offering
- 6.3.6.5.2 By Application
- 6.3.6.6 Rest-of-Europe
- 6.3.6.6.1 By Offering
- 6.3.6.6.2 By Application
- 6.4 Asia-Pacific
- 6.4.1 Regional Overview
- 6.4.2 Driving Factors for Market Growth
- 6.4.3 Factors Challenging the Market
- 6.4.4 By Offering
- 6.4.4.1 By Proteomics Technologies
- 6.4.5 By Application
- 6.4.6 By Country
- 6.4.6.1 Japan
- 6.4.6.1.1 By Offering
- 6.4.6.1.2 By Application
- 6.4.6.2 China
- 6.4.6.2.1 By Offering
- 6.4.6.2.2 Application
- 6.4.6.3 India
- 6.4.6.3.1 By Offering
- 6.4.6.3.2 By Application
- 6.4.6.4 Australia
- 6.4.6.4.1 By Offering
- 6.4.6.4.2 By Application
- 6.4.6.5 South Korea
- 6.4.6.5.1 By Offering
- 6.4.6.5.2 By Application
- 6.4.6.6 Rest-of-Asia-Pacific
- 6.4.6.6.1 By Offering
- 6.4.6.6.2 By Application
- 6.5 Latin America
- 6.5.1 Regional Overview
- 6.5.2 Driving Factors for Market Growth
- 6.5.3 Factors Challenging the Market
- 6.5.4 By Offering
- 6.5.4.1 By Proteomics Technologies
- 6.5.5 By Application
- 6.5.6 By Country
- 6.5.6.1 Brazil
- 6.5.6.1.1 By Offering
- 6.5.6.1.2 By Application
- 6.5.6.2 Mexico
- 6.5.6.2.1 By Offering
- 6.5.6.2.2 By Application
- 6.5.6.3 Rest-of-Latin America
- 6.5.6.3.1 By Offering
- 6.5.6.3.2 By Application
- 6.6 Middle East and Africa
- 6.6.1 Regional Overview
- 6.6.2 Driving Factors for Market Growth
- 6.6.3 Factors Challenging the Market
- 6.6.4 By Offering
- 6.6.4.1 By Proteomics Technologies
- 6.6.5 By Application
- 7 Markets - Competitive Benchmarking & Company Profiles
- 7.1 Company Profiles
- 7.1.1 Agilent Technologies, Inc.
- 7.1.1.1 Overview
- 7.1.1.2 Top Products/Product Portfolio
- 7.1.1.3 Top Competitors
- 7.1.1.4 Target Customers
- 7.1.1.5 Key Personal
- 7.1.1.6 Analyst View
- 7.1.2 Becton, Dickinson and Company
- 7.1.2.1 Overview
- 7.1.2.2 Top Products/Product Portfolio
- 7.1.2.3 Top Competitors
- 7.1.2.4 Target Customers
- 7.1.2.5 Key Personal
- 7.1.2.6 Analyst View
- 7.1.3 Bio-Rad Laboratories, Inc.
- 7.1.3.1 Overview
- 7.1.3.2 Top Products/Product Portfolio
- 7.1.3.3 Top Competitors
- 7.1.3.4 Target Customers
- 7.1.3.5 Key Personal
- 7.1.3.6 Analyst View
- 7.1.4 Bruker Corporation
- 7.1.4.1 Overview
- 7.1.4.2 Top Products/Product Portfolio
- 7.1.4.3 Top Competitors
- 7.1.4.4 Target Customers
- 7.1.4.5 Key Personal
- 7.1.4.6 Analyst View
- 7.1.5 Carterra, Inc.
- 7.1.5.1 Overview
- 7.1.5.2 Top Products/Product Portfolio
- 7.1.5.3 Top Competitors
- 7.1.5.4 Target Customers
- 7.1.5.5 Key Personal
- 7.1.5.6 Analyst View
- 7.1.6 Danaher Corporation
- 7.1.6.1 Overview
- 7.1.6.2 Top Products/Product Portfolio
- 7.1.6.3 Top Competitors
- 7.1.6.4 Target Customers
- 7.1.6.5 Key Personal
- 7.1.6.6 Analyst View
- 7.1.7 DiaSorin S.P.A.
- 7.1.7.1 Overview
- 7.1.7.2 Top Products/Product Portfolio
- 7.1.7.3 Top Competitors
- 7.1.7.4 Target Customers
- 7.1.7.5 Key Personal
- 7.1.7.6 Analyst View
- 7.1.8 Erisyon Inc.
- 7.1.8.1 Overview
- 7.1.8.2 Top Products/Product Portfolio
- 7.1.8.3 Top Competitors
- 7.1.8.4 Target Customers
- 7.1.8.5 Key Personal
- 7.1.8.6 Analyst View
- 7.1.8.7 Market Share, 2023
- 7.1.9 Illumina, Inc.
- 7.1.9.1 Overview
- 7.1.9.2 Top Products/Product Portfolio
- 7.1.9.3 Top Competitors
- 7.1.9.4 Target Customers
- 7.1.9.5 Key Personal
- 7.1.9.6 Analyst View
- 7.1.10 RareCyte Inc.
- 7.1.10.1 Overview
- 7.1.10.2 Top Products/Product Portfolio
- 7.1.10.3 Top Competitors
- 7.1.10.4 Target Customers
- 7.1.10.5 Key Personal
- 7.1.10.6 Analyst View
- 7.1.11 Quanterix Corporation
- 7.1.11.1 Overview
- 7.1.11.2 Top Competitors
- 7.1.11.3 Target Customers
- 7.1.11.4 Key Personal
- 7.1.11.5 Analyst View
- 7.1.11.6 Market Share, 2023
- 7.1.12 Quantum-Si Incorporated
- 7.1.12.1 Overview
- 7.1.12.2 Top Products/Product Portfolio
- 7.1.12.3 Top Competitors
- 7.1.12.4 Target Customers
- 7.1.12.5 Key Personal
- 7.1.12.6 Analyst View
- 7.1.13 Shimadzu Corporation
- 7.1.13.1 Overview
- 7.1.13.2 Top Products/Product Portfolio
- 7.1.13.3 Top Competitors
- 7.1.13.4 Target Customers
- 7.1.13.5 Key Personal
- 7.1.13.6 Analyst View
- 7.1.14 Standard BioTools Inc.
- 7.1.14.1 Overview
- 7.1.14.2 Top Products/Product Portfolio
- 7.1.14.3 Top Competitors
- 7.1.14.4 Target Customers
- 7.1.14.5 Key Personal
- 7.1.14.6 Analyst View
- 7.1.15 Thermo Fisher Scientific Inc.
- 7.1.15.1 Overview
- 7.1.15.2 Top Products/Product Portfolio
- 7.1.15.3 Top Competitors
- 7.1.15.4 Target Customers
- 7.1.15.5 Key Personal
- 7.1.15.6 Analyst View
- 7.1.16 Waters Corporation
- 7.1.16.1 Overview
- 7.1.16.2 Top Products/Product Portfolio
- 7.1.16.3 Top Competitors
- 7.1.16.4 Target Customers
- 7.1.16.5 Key Personal
- 7.1.16.6 Analyst View
- 8 Research Methodology
- 8.1 Data Sources
- 8.1.1 Primary Data Sources
- 8.1.2 Secondary Data Sources
- 8.1.3 Data Triangulation
- 8.2 Market Estimation and Forecast
- List of Figures
- Figure 1: Global Proteomics Market (by Scenario), $Billion, 2024, 2030, and 2035
- Figure 2: Global Proteomics Market, $Billion, 2024 and 2035
- Figure 3: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
- Figure 4: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
- Figure 5: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
- Figure 6: Global Proteomics Market (by End User), $Billion, 2024, 2030, and 2035
- Figure 7: Global Proteomics Market Segmentation
- Figure 8: Ecosystem Global Proteomics Market
- Figure 9: Supply Chain and Risks within the Supply Chain
- Figure 10: Global Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
- Figure 11: Global Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
- Figure 12: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
- Figure 13: Global Proteomics Market (Sample Preparation), $Billion, 2024-2035
- Figure 14: Global Proteomics Market (Proteomics Technologies), $Billion, 2024-2035
- Figure 15: Global Proteomics Market (by Proteomics Technologies, Reagents and Consumables), $Billion, 2024-2035
- Figure 16: Global Proteomics Market (by Reagents and Consumables, MS-Based Reagents), $Billion, 2024-2035
- Figure 17: Global Proteomics Market (by Reagents and Consumables, Chromatography-Based Reagents), $Billion, 2024-2035
- Figure 18: Global Proteomics Market (by Reagents and Consumables, Protein Microarray Reagents), $Billion, 2024-2035
- Figure 19: Global Proteomics Market (by Reagents and Consumables, Single-Cell Analysis Reagents), $Billion, 2024-2035
- Figure 20: Global Proteomics Market (by Reagents and Consumables, NGS-Based Reagents), $Billion, 2024-2035
- Figure 21: Global Proteomics Market (by Reagents and Consumables, Other Reagents), $Billion, 2024-2035
- Figure 22: Global Proteomics Market (by Proteomics Technologies, Instruments), $Billion, 2024-2035
- Figure 23: Global Proteomics Market (by Instruments, Mass Spectrometers), $Billion, 2024-2035
- Figure 24: Global Proteomics Market (by Instruments, Chromatography Systems), $Billion, 2024-2035
- Figure 25: Global Proteomics Market (by Instruments, Protein Microarrays), $Billion, 2024-2035
- Figure 26: Global Proteomics Market (by Instruments, Single-Cell Analysis Instruments), $Billion, 2024-2035
- Figure 27: Global Proteomics Market (by Instruments, NGS Instruments), $Billion, 2024-2035
- Figure 28: Global Proteomics Market (by Instruments, Other Instruments), $Billion, 2024-2035
- Figure 29: Global Proteomics Market (by Proteomics Technologies, Software), $Billion, 2024-2035
- Figure 30: Global Proteomics Market (by Software, AI-Based Proteomics Analysis Tools), $Billion, 2024-2035
- Figure 31: Global Proteomics Market (by Software, Spatial Proteomics Data Analytic Software), $Billion, 2024-2035
- Figure 32: Global Proteomics Market (by Software, Cloud-Based Platforms), $Billion, 2024-2035
- Figure 33: Global Proteomics Market (Proteomics Services), $Billion, 2024-2035
- Figure 34: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
- Figure 35: Global Proteomics Market (Biomarker Discovery and Validation), $Billion, 2024-2035
- Figure 36: Global Proteomics Market (Proteomics Profiling and Mapping), $Billion, 2024-2035
- Figure 37: Global Proteomics Market (Drug Discovery and Development), $Billion, 2024-2035
- Figure 38: Global Proteomics Market (by Drug Discovery and Development, Discovery), $Billion, 2024-2035
- Figure 39: Global Proteomics Market (by Discovery, Target Identification and Validation), $Billion, 2024-2035
- Figure 40: Global Proteomics Market (by Discovery, Others), $Billion, 2024-2035
- Figure 41: Global Proteomics Market (by Drug Discovery and Development, Preclinical), $Billion, 2024-2035
- Figure 42: Global Proteomics Market (by Drug Discovery and Development, Clinical), $Billion, 2024-2035
- Figure 43: Global Proteomics Market (Companion Diagnostics), $Billion, 2024-2035
- Figure 44: Global Proteomics Market (Protein-Protein Interactions), $Billion, 2024-2035
- Figure 45: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
- Figure 46: Global Proteomics Market (Mass Spectrometry-Based Proteomics), $Billion, 2024-2035
- Figure 47: Global Proteomics Market (Chromatography-Based Proteomics), $Billion, 2024-2035
- Figure 48: Global Proteomics Market (Protein Microarray), $Billion, 2024-2035
- Figure 49: Global Proteomics Market (Single-Cell Proteomics), $Billion, 2024-2035
- Figure 50: Global Proteomics Market (NGS-Based Proteomics), $Billion, 2024-2035
- Figure 51: Global Proteomics Market (Other Technologies), $Billion, 2024-2035
- Figure 52: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
- Figure 53: Global Proteomics Market (Academic and Research Institutions), $Billion, 2024-2035
- Figure 54: Global Proteomics Market (Pharmaceutical and Biotechnology Companies), $Billion, 2024-2035
- Figure 55: Global Proteomics Market (Hospitals and Clinical Diagnostics Laboratories), $Billion, 2024-2035
- Figure 56: Global Proteomics Market (Contract Research Organizations), $Billion, 2024-2035
- Figure 57: U.S. Proteomics Market, $Billion, 2024-2035
- Figure 58: Canada Proteomics Market, $Billion, 2024-2035
- Figure 59: U.K. Proteomics Market, $Billion, 2024-2035
- Figure 60: Germany Proteomics Market, $Billion, 2024-2035
- Figure 61: France Proteomics Market, $Billion, 2024-2035
- Figure 62: Italy Proteomics Market, $Billion, 2024-2035
- Figure 63: Spain Proteomics Market, $Billion, 2024-2035
- Figure 64: Rest-of-Europe Proteomics Market, $Billion, 2024-2035
- Figure 65: Japan Proteomics Market, $Billion, 2024-2035
- Figure 66: China Proteomics Market, $Billion, 2024-2035
- Figure 67: India Proteomics Market, $Billion, 2024-2035
- Figure 68: Australia Proteomics Market, $Billion, 2024-2035
- Figure 69: South Korea Proteomics Market, $Billion, 2024-2035
- Figure 70: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2024-2035
- Figure 71: Brazil Proteomics Market, $Billion, 2024-2035
- Figure 72: Mexico Proteomics Market, $Billion, 2024-2035
- Figure 73: Rest-of-Latin America Proteomics Market, $Billion, 2024-2035
- Figure 74: Data Triangulation
- Figure 75: Top-Down and Bottom-Up Approach
- Figure 76: Assumptions and Limitations
- List of Tables
- Table 1: Market Snapshot
- Table 2: Opportunities across Regions
- Table 3: Partnerships and Collaborations in the Global Proteomics Market
- Table 4: Global Proteomics Market, Product Benchmarking (by Technology)
- Table 5: Global Proteomics Market (by Region), $Billion, 2024-2035
- Table 6: North America Proteomics Market (by Offering), $Billion, 2024-2035
- Table 7: North America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 8: North America Proteomics Market (by Application), $Billion, 2024-2035
- Table 9: U.S. Proteomics Market (by Offering), $Billion, 2024-2035
- Table 10: U.S. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 11: U.S. Proteomics Market (by Application), $Billion, 2024-2035
- Table 12: Canada Proteomics Market (by Offering), $Billion, 2024-2035
- Table 13: Canada Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 14: Canada Proteomics Market (by Application), $Billion, 2024-2035
- Table 15: Europe Proteomics Market (by Offering), $Billion, 2024-2035
- Table 16: Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 17: Europe Proteomics Market (by Application), $Billion, 2024-2035
- Table 18: U.K. Proteomics Market (by Offering), $Billion, 2024-2035
- Table 19: U.K. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 20: U.K. Proteomics Market (by Application), $Billion, 2024-2035
- Table 21: Germany Proteomics Market (by Offering), $Billion, 2024-2035
- Table 22: Germany Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 23: Germany Proteomics Market (by Application), $Billion, 2024-2035
- Table 24: France Proteomics Market (by Offering), $Billion, 2024-2035
- Table 25: France Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 26: France Proteomics Market (by Application), $Billion, 2024-2035
- Table 27: Italy Proteomics Market (by Offering), $Billion, 2024-2035
- Table 28: Italy Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 29: Italy Proteomics Market (by Application), $Billion, 2024-2035
- Table 30: Spain Proteomics Market (by Offering), $Billion, 2024-2035
- Table 31: Spain Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 32: Spain Proteomics Market (by Application), $Billion, 2024-2035
- Table 33: Rest-of-Europe Proteomics Market (by Offering), $Billion, 2024-2035
- Table 34: Rest-of-Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 35: Rest-of-Europe Proteomics Market (by Application), $Billion, 2024-2035
- Table 36: Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
- Table 37: Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 38: Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
- Table 39: Japan Proteomics Market (by Offering), $Billion, 2024-2035
- Table 40: Japan Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 41: Japan Proteomics Market (by Application), $Billion, 2024-2035
- Table 42: China Proteomics Market (by Offering), $Billion, 2024-2035
- Table 43: China Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 44: China Proteomics Market (by Application), $Billion, 2024-2035
- Table 45: India Proteomics Market (by Offering), $Billion, 2024-2035
- Table 46: India Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 47: India Proteomics Market (by Application), $Billion, 2024-2035
- Table 48: Australia Proteomics Market (by Offering), $Billion, 2024-2035
- Table 49: Australia Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 50: Australia Proteomics Market (by Application), $Billion, 2024-2035
- Table 51: South Korea Proteomics Market (by Offering), $Billion, 2024-2035
- Table 52: South Korea Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 53: South Korea Proteomics Market (by Application), $Billion, 2024-2035
- Table 54: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
- Table 55: Rest-of-Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 56: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
- Table 57: Latin America Proteomics Market (by Offering), $Billion, 2024-2035
- Table 58: Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 59: Latin America Proteomics Market (by Application), $Billion, 2024-2035
- Table 60: Brazil Proteomics Market (by Offering), $Billion, 2024-2035
- Table 61: Brazil Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 62: Brazil Proteomics Market (by Application), $Billion, 2024-2035
- Table 63: Mexico Proteomics Market (by Offering), $Billion, 2024-2035
- Table 64: Mexico Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 65: Mexico Proteomics Market (by Application), $Billion, 2024-2035
- Table 66: Rest-of-Latin America Proteomics Market (by Offering), $Billion, 2024-2035
- Table 67: Rest-of-Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 68: Rest-of-Latin America Proteomics Market (by Application), $Billion, 2024-2035
- Table 69: Middle East and Africa Proteomics Market (by Offering), $Billion, 2024-2035
- Table 70: Middle East and Africa Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
- Table 71: Middle East and Africa Proteomics Market (by Application), $Billion, 2024-2035
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
